527 related articles for article (PubMed ID: 20501944)
41. Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency.
Cameron MD; Schmidt EE; Kerkvliet N; Nadkarni KV; Morris VL; Groom AC; Chambers AF; MacDonald IC
Cancer Res; 2000 May; 60(9):2541-6. PubMed ID: 10811137
[TBL] [Abstract][Full Text] [Related]
42. Interleukin-33 pretreatment promotes metastatic growth of murine melanoma by reducing the cytotoxic capacity of CD8
Jevtovic A; Pantic J; Jovanovic I; Milovanovic M; Stanojevic I; Vojvodic D; Arsenijevic N; Lukic ML; Radosavljevic GD
Cancer Immunol Immunother; 2020 Aug; 69(8):1461-1475. PubMed ID: 32285171
[TBL] [Abstract][Full Text] [Related]
43. Skin melanoma development in ret transgenic mice despite the depletion of CD25+Foxp3+ regulatory T cells in lymphoid organs.
Kimpfler S; Sevko A; Ring S; Falk C; Osen W; Frank K; Kato M; Mahnke K; Schadendorf D; Umansky V
J Immunol; 2009 Nov; 183(10):6330-7. PubMed ID: 19841169
[TBL] [Abstract][Full Text] [Related]
44. Targeting the primary tumor to generate CTL for the effective eradication of spontaneous metastases.
Yu P; Lee Y; Wang Y; Liu X; Auh S; Gajewski TF; Schreiber H; You Z; Kaynor C; Wang X; Fu YX
J Immunol; 2007 Aug; 179(3):1960-8. PubMed ID: 17641063
[TBL] [Abstract][Full Text] [Related]
45. Changes in the TCRβ Repertoire and Tumor Immune Signature From a Cutaneous Melanoma Patient Immunized With the CSF-470 Vaccine: A Case Report.
Aris M; Bravo AI; Pampena MB; Blanco PA; Carri I; Koile D; Yankilevich P; Levy EM; Barrio MM; Mordoh J
Front Immunol; 2018; 9():955. PubMed ID: 29774030
[TBL] [Abstract][Full Text] [Related]
46. Metastases in immune-mediated dormancy: a new opportunity for targeting cancer.
Romero I; Garrido F; Garcia-Lora AM
Cancer Res; 2014 Dec; 74(23):6750-7. PubMed ID: 25411345
[TBL] [Abstract][Full Text] [Related]
47. Complete regression of advanced primary and metastatic mouse melanomas following combination chemoimmunotherapy.
Kohlmeyer J; Cron M; Landsberg J; Bald T; Renn M; Mikus S; Bondong S; Wikasari D; Gaffal E; Hartmann G; Tüting T
Cancer Res; 2009 Aug; 69(15):6265-74. PubMed ID: 19622767
[TBL] [Abstract][Full Text] [Related]
48. Transient T cell depletion causes regression of melanoma metastases.
Rasku MA; Clem AL; Telang S; Taft B; Gettings K; Gragg H; Cramer D; Lear SC; McMasters KM; Miller DM; Chesney J
J Transl Med; 2008 Mar; 6():12. PubMed ID: 18334033
[TBL] [Abstract][Full Text] [Related]
49. MRI surveillance of cancer cell fate in a brain metastasis model after early radiotherapy.
Murrell DH; Zarghami N; Jensen MD; Dickson F; Chambers AF; Wong E; Foster PJ
Magn Reson Med; 2017 Oct; 78(4):1506-1512. PubMed ID: 27851873
[TBL] [Abstract][Full Text] [Related]
50. Immunomodulatory Protective Effects of Rb9 Cyclic-Peptide in a Metastatic Melanoma Setting and the Involvement of Dendritic Cells.
Machado FC; Girola N; Maia VSC; Bergami-Santos PC; Morais AS; Azevedo RA; Figueiredo CR; Barbuto JAM; Travassos LR
Front Immunol; 2019; 10():3122. PubMed ID: 32010152
[TBL] [Abstract][Full Text] [Related]
51. Selective depletion of Foxp3+ regulatory T cells improves effective therapeutic vaccination against established melanoma.
Klages K; Mayer CT; Lahl K; Loddenkemper C; Teng MW; Ngiow SF; Smyth MJ; Hamann A; Huehn J; Sparwasser T
Cancer Res; 2010 Oct; 70(20):7788-99. PubMed ID: 20924102
[TBL] [Abstract][Full Text] [Related]
52. Cancer Metastases: Early Dissemination and Late Recurrences.
Friberg S; Nyström A
Cancer Growth Metastasis; 2015; 8():43-9. PubMed ID: 26640389
[TBL] [Abstract][Full Text] [Related]
53. Specific autologous anti-melanoma T cell response in vitro using monocyte-derived dendritic cells.
Soruri A; Fayyazi A; Gieseler R; Schlott T; Rünger TM; Neumann C; Peters JH
Immunobiology; 1998 Mar; 198(5):527-38. PubMed ID: 9561371
[TBL] [Abstract][Full Text] [Related]
54. Cannibalism of live lymphocytes by human metastatic but not primary melanoma cells.
Lugini L; Matarrese P; Tinari A; Lozupone F; Federici C; Iessi E; Gentile M; Luciani F; Parmiani G; Rivoltini L; Malorni W; Fais S
Cancer Res; 2006 Apr; 66(7):3629-38. PubMed ID: 16585188
[TBL] [Abstract][Full Text] [Related]
55. Cell-intrinsic survival signals. The role of autophagy in metastatic dissemination and tumor cell dormancy.
Vera-Ramirez L
Semin Cancer Biol; 2020 Feb; 60():28-40. PubMed ID: 31400500
[TBL] [Abstract][Full Text] [Related]
56. Tumor cell dormancy.
Gomis RR; Gawrzak S
Mol Oncol; 2017 Jan; 11(1):62-78. PubMed ID: 28017284
[TBL] [Abstract][Full Text] [Related]
57. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
[TBL] [Abstract][Full Text] [Related]
58. Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model.
Mairhofer DG; Ortner D; Tripp CH; Schaffenrath S; Fleming V; Heger L; Komenda K; Reider D; Dudziak D; Chen S; Becker JC; Flacher V; Stoitzner P
J Invest Dermatol; 2015 Nov; 135(11):2785-2793. PubMed ID: 26121214
[TBL] [Abstract][Full Text] [Related]
59. Disseminated human malignant melanoma in congenitally immune-deficient (bg/nu/xid) mice.
Mulé JJ; Jicha DL; Aebersold PM; Travis WD; Rosenberg SA
J Natl Cancer Inst; 1991 Mar; 83(5):350-5. PubMed ID: 1995918
[TBL] [Abstract][Full Text] [Related]
60. Incubation of antigen-sensitized T lymphocytes activated with bryostatin 1 + ionomycin in IL-7 + IL-15 increases yield of cells capable of inducing regression of melanoma metastases compared to culture in IL-2.
Le HK; Graham L; Miller CH; Kmieciak M; Manjili MH; Bear HD
Cancer Immunol Immunother; 2009 Oct; 58(10):1565-76. PubMed ID: 19198835
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
